[Review of current pharmacotherapy of Parkinsonism. Comprehensive review].
D006916:5-Hydroxytryptophan / Q000627:therapeutic use; D000547:Amantadine / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D001058:Apomorphine / Q000627:therapeutic use; D001590:Benztropine / Q000627:therapeutic use; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D055598:Chemical Phenomena; D002621:Chemistry; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D011352:Procyclidine / Q000627:therapeutic use; D014282:Trihexyphenidyl / Q000627:therapeutic use
D000927:Anticonvulsants; D010276:Parasympatholytics; D001590:Benztropine; D004295:Dihydroxyphenylalanine; D014282:Trihexyphenidyl; D000547:Amantadine; D006916:5-Hydroxytryptophan; D011352:Procyclidine; D002262:Carboxy-Lyases; D001058:Apomorphine
Prehled soucasné farmakoterapie parkinsonovy nemoci. Souborný referát.